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Abstract
Allergic rhinitis (AR) is a symptomatic disorder of the nose induced after allergen exposure by an immunoglobulin 
E (IgE)-mediated inflammation of the membranes lining the nose. The manifestation of AR can affect patients’ 
quality of life. The objective of this study was to evaluate the profile of allergic rhinitis patients in term of nasal 
eosinophil count, total nasal symptom score (TNSS) and peak nasal inspiratory flow (PNIF). Fourteen allergic 
rhinitis patients were evaluated using the nasal eosinophil count with Wright-Giemsa staining, total nasal symptom 
score, and PNIF. The study comprised of 6 (42.9%) men, and 8 (57.1%) women with a mean of age 21.15±3.78 
years. Participants’ symptoms and characteristics included sneezing (42%), nasal blockage (21.4%), itchy nose 
(21.4%), and rinorrhea (14.3%) with a mean TNSS of 8.2±1.8. Intermittent AR was found in 14.3% subjects, 
persistent AR 78.6%, mild AR 21.4%, and moderate-severe AR 78.6%. The mean PNIF was 80±27.46 L/min, and 
mean eosinophil count of 2.5±1.74. In conclusion, allergic rhinitis patients demonstrated positive nasal eosinophil 
count with Wright-Giemsa staining, with the majority of them having persistent and moderate-severe RA. They also 
had nasal airflow impairment, which could affect quality of life.
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 Profil Rinitis Alergika Berdasarkan Hitung Eosinofil, Total Nasal Symptoms Score 
dan Peak Nasal Inspiratory Flow
Abstrak 
Rhinitas alergika (RA) merupakan kelainan pada hidung yang diinduksi oleh pajanan alergen yang berhubungan 
dengan reaksi inflamasi yang diperantarai IgE pada mokusa hidung. Manifestasi RA dapat mempengaruhi kualitas 
hidup pasien. Tujuan penelitian  ini adalah simptomatik evaluasi profil pasien RA dari segi hitung eosinofil nasal, 
skor total sindrom nasal (TNSS) dan aliran inspirasi nasal (PNIF). Empat belas pasien RA dievaluasi jumlah 
eosinofil nasal dengan pewarnaan Wright-Giemsa, skor total simtom nasal dan PNIF. Terdapat 6 (42,9%) laki –laki 
dan 8 (57,1%) perempuan dengan umur rata-rata usia 21,15±3.78 tahun.  Simtom dan karakteristik pasien yaitu 
bersin (42%), sumbatan hidung (21,4%), hidung gatal (21,4%) dan rinorea (14,3%), dengan rata-rata TNSS 8.2±1.8. 
Rinitas alergika intermiten ditemukan pada 14,3% subyek, yang persisten 78,6%, sedang 21,4% serta sedang-berat 
78,6%. Rata-rata PNIF 80±27.46 L/menit, serta rata-rata jumlah eosinofil 2.5±1.74. Dapat disimpulkan pasien RA 
menunjukkan jumlah eosinofil nasal positif dengan pewarnaan Wright- Giemsa dan kebanyakan memiliki RA yang 
persisten dengan tingkat sedang-berat. Terdapat juga gangguan aliran udara hidung yang mungkin mempengaruhi 
kualitas hidup mereka. 
Kata Kunci: rinitis alergika, eosinofil, aliran udara hidung, kualitas hidung
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atopic diseases are caused by a deficiency of 
Treg. The Treg play an important role in the 
regulation of Th1 and Th2.12 Genetic factors 
such as the atopic history of the family, is 
the strongest factor in the development of 
allergic symptoms.13 
Allergic rhinitis is not a dangerous 
disease, but the symptoms can affect patient’s 
quality of life.14 The cost of this disease can 
make an impact on a nation’s economy, 
and half of the cost is used for prescription 
medication.1 A decrease in productivity and 
missed work can cause economic problems, 
and AR can impact, health insurance due to 
exacerbations and complications of allergic 
disease.15
Allergic rhinitis can be diagnosed 
by anamnesis, physical examination and 
additional examination by using allergic 
tests, whether it is in vivo or in vitro, but on 
allergic tests, that many more people have 
positive result than have AR.1 Patients with 
nasal symptoms who had a family atopic 
history can have a stronger AR diagnosis. 
Nasal eosinophil count can be used as an 
additional examination in the health facilities 
that have limited skin prick tests.16 The 
degree of AR symptoms can be measured 
by using a scoring system of symptom that 
is easily understood by the patient, which 
will be related to daily activity. The total 
nasal symptoms score (TNSS) is the overall 
symptom score of AR, and is often used 
to evaluate the AR treatment.17,18 Higher 
values on the TNSS show more severe AR 
symptoms. Allergic rhinitis manifestation 
based on the duration of the symptoms can be 
classified as intermittent and persistent. The 
degree of severity can be classified as mild, 
if there are no problems in daily activity, 
and moderate-severe if there are problems 
in daily activity.2 Nasal airflow and patency 
can be objectively examined by using peak 
nasal inspiratory flow (PNIF).19 Low value 
for PNIF shows that there is reduced nasal 
airflow and patency. 
Introduction
Allergic rhinitis is a symptomatic 
disorder of the nose induced after allergen 
exposure by an immunoglobulin E (IgE)-
mediated inflammation of the membranes 
lining the nose.1,2 The symptoms of nasal 
reactions occurring in allergies are sneezing, 
nasal obstruction, mucous discharge 
(rhinorrhea) and /or itching of the nose.2 
These symptoms occur during two or more 
consecutive days for more than 1 hour on 
most days.3
The prevalence of allergic disease in 
the United States (US) is 20%, and is still 
increasing.4 A survey published in 2006 
recorded that 54.6% of individuals in the 
US test positively for at least 1 allergen.5 
The prevalence of AR in the Asia-Pacific 
countries such as Australia, China, Hong 
Kong, Malaysia, Philippines, Taiwan and 
Vietnam,  ranges on average from 4.2-
13.2%.6 Allergic rhinitis is rarely found in 
people under the age of 5 years old, and it 
peaks between the ages of 17 and 22 years 
old.5 With regard to the relationship between 
gender and AR,  cases are found in women 
more often than man.7, 8 
Allergic rhinitis develops from 
environmental, immunologic and genetic 
factors.9 Environmental factors include 
aeroallergens, such as mites and cockroaches, 
and are significantly related to the persistence 
of RA. The degree of AR is significantly 
related the allergen concentration in the 
environment.10 Indonesia is a country without 
a spring season, which can lead to lighter 
symptoms because of the allergen exposure 
and low concentration over a period of years 
(perennial).11 Other environment factors 
such as temperature, humidity, pollution 
and lifestyle, significantly influence the 
manifestation of AR. The immunologic 
factor is related to the role of Th1 and Th2. 
The latest concept of allergic disease is the 
role of regulatory T cells (Treg), and the 
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Symptom assessment, nasal eosinophil 
count and peak nasal inspiratory flow were 
performed in all patients. This study obtained 
ethical approval from Rumah Sakit Umum 
UKI Jakarta.
Nasal Symptoms
The following symptoms were assessed 
with clinical interview: nasal obstruction, 
sneezing, rhinorrhea, and itchy nose. Each 
symptom was evaluated on the following 
scale: 0 = absent, 1 = mild (symptom 
was present but was not annoying or 
troublesome), 2 = moderate (symptom was 
frequently troublesome but did not interfere 
with either normal daily activity or sleep), 
and 3 = severe (symptom was sufficiently 
troublesome to have interfered with normal 
daily activity or sleep). Total nasal symptom 
score was the sum of each individual 
symptom and was considered as described 
in previous reports.20
Nasal Eosinophil Count
The nasal eosinophil count was 
determined by scraping the head of the 
inferior turbinate with a cytobrush (usually 
used for cervix cytology examination, made 
in Indonesia with Swedish license), rotating 
it three times, creating a smear with the 
Wright-Giemsa stain and analyzed by optic 
microscope (Olympus CX21LED, Olympus 
Corporation, Tokyo, Japan). The number of 
eosinophils was expressed as a mean of 10 
optical fields at a magnification of 100. 
The aim of this study was to determine 
the profile of allergic rhinitis patients in 
terms of nasal eosinophil count, total nasal 
symptom score and peak nasal inspiratory 
flow.
Material and Methods 
Patients
Fourteen patents with allergic rhinitis 
symptoms, six men and eight women had 
a detailed clinical history and a complete 
physical examination. The diagnosis of 
persistent, intermittent, mild and moderate-
severe allergic rhinitis was made according 
to ARIA guidelines and on the basis of one’s 
history of allergy to house dust.
Study Design
This research was a cross-sectional 
study of patients aged 15-55 years old 
diagnosed with AR based on ARIA-WHO 
2008 criteria who came to the Ear Nose and 
Throat Department at Rumah Sakit Umum 
UKI, Jakarta in 2016. The participants 
were recruited with consecutive sampling 
technique. All patients were asked for their 
informed consent to be participants in this 
study. Patients with acute and chronic upper 
respiratory infections within 30 days before 
the study, anatomic nasal disorders (i.e., 
septum deviation), nasal polyps, nasal or oral 
corticosteroids within the previous 4 weeks, 
and use antihistamines within the previous 
week were excluded from the study. 
Figure 1. Displays three images showing nasal mucosal eosinophils (red arrows) in Wright-Giemsa staining.
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Results   
Fourteen patients with AR, 6 (42%) men 
and 8 (57.1%) women with a mean of age 
21.15±3.78 years were included in the study 
and had the following nasal symptoms; 
sneezing (42%), itching (21.4%), nasal 
blockage (21.4%) and rhinorrhea (14.3%), 
with a mean TNSS of 8.2±1.8 (Table 1). 
Intermittent AR was found in 14.3% patients, 
persistent AR 78.6%, mild AR 21.4%, and 
moderate-severe AR 78.6%. The mean PNIF 
was 80±27.46 L/Min, while the mean nasal 
eosinophil count was 2.5±1.74 cells. 
Discussion 
This study examined patients with AR 
with a mean of age 21 years old. Similarly, 
other study showed the peak incidence of 
AR occurred between 17 to 22 years of age.5 
The number of AR cases among women was 
higher then men. Other studies also found 
significant differences between men and 
women, such that AR was found more often 
in women than in men.8, 21 
The common clinical symptoms of 
AR are itchy nose followed by recurrent 
sneezing, rhinorrhea and nasal blockage.2 In 
the other cases, these symptom were followed 
by itchy eyes, itchy ear, and itchy palatum 
molle. In this study, sneezing was the most 
common symptom, which is consistent with 
other study where 90% of the participants 
complaining of severe sneezing.22 
The mean TNSS in this study was 
7.92±1.9, which is comparable to other 
study that found the TNSS in patients with 
AR was 7.1±2 and without AR 1.9±1.23 
A mean TNSS of 7.9 shows that the AR 
symptoms were severe. This study found 
that most cases of AR, based on the time 
period of symptoms, were persistent AR. The 
persistence of AR correlates significantly 
with the presence of aeroallergens, such as 
mites and cockroaches.24 This study also 
Peak Nasal Inspiratory Flow
Nasal airflow and patency were 
measured by peak nasal inspiratory flow 
with In-Check Nasal, Clement Clarke 
International Limited, as described in 
previous reports,20 in the following way: . 
Hold the In-Check horizontally, and ensure 
the face mask forms an air tight seal around 
the nose. The patients were asked to exhale 
fully, close their mouth, and inhale forcefully 
through their noses (sniff). The examination 
was repeated to obtain three readings, with 
the highest reading recorded in the patient’s 
notes, (L/Min).
Figure 2. Peak Nasal Inspiration Flow (PNIF).
Statistical Analysis
The research data were collected, 
tabulated and processed. The data then 
were analyzed descriptively in term of 
percentages, means and standard deviations 
(SDs), and the data presented in tables. 
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vasodilatation of the blood vessels in the 
nose, and contraction of the vena cushion 
and venule compression because of the 
dilated artery in the intraosseous canal from 
periosteal cavity.26
Conclusion
Allergic rhinitis patients had an increased 
nasal eosinophil count. The most frequent 
AR cases were persistent and moderate-
severe based on the total nasal symptom 
score. Additionally, there was nasal airflow 
impairment, which could affect quality of 
life. 
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